SNSE (Sensei Biotherapeutics, Inc. Common Stock) Stock Analysis - SEC Filings
Sensei Biotherapeutics, Inc. Common Stock (SNSE) is a publicly traded Healthcare sector company. As of May 21, 2026, SNSE trades at $17.58 with a market cap of $26.70M and a P/E ratio of -1.04. SNSE moved +4.59% today. Year to date, SNSE is +80.68%; over the trailing twelve months it is +167.91%. Its 52-week range spans $5.00 to $36.76. Rallies surfaces SNSE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Where can I find SNSE SEC filings?
Rallies organizes SNSE SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.